115 related articles for article (PubMed ID: 16713202)
1. Synthesis of radiolabelled 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a neurotoxic chloral-derived mammalian alkaloid, and its biodistribution in rats.
Bringmann G; Feineis D; Brückner R; God R; Grote C; Wesemann W
Eur J Pharm Sci; 2006 Aug; 28(5):412-22. PubMed ID: 16713202
[TBL] [Abstract][Full Text] [Related]
2. The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons.
Bringmann G; God R; Feineis D; Wesemann W; Riederer P; Rausch WD; Reichmann H; Sontag KH
J Neural Transm Suppl; 1995; 46():235-44. PubMed ID: 8821060
[TBL] [Abstract][Full Text] [Related]
3. [The plasma level of the neurotoxin 1-trichloromethyl-1,2,4,5-tetrahydro-beta-carboline (TaClo) in man after oral administration of chloral hydrate].
Leuschner J; Beuscher N; Zimmermann T; Schürer M; Schulz HU; Jeromin J; Ritter H
Arzneimittelforschung; 1998 Jan; 48(1):1-5. PubMed ID: 9522023
[TBL] [Abstract][Full Text] [Related]
4. Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives.
Grote C; Clement HW; Wesemann W; Bringmann G; Feineis D; Riederer P; Sontag KH
J Neural Transm Suppl; 1995; 46():275-81. PubMed ID: 8821064
[TBL] [Abstract][Full Text] [Related]
5. Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2, 3,4-tetrahydro-beta-carboline in human blood after intake of the hypnotic chloral hydrate.
Bringmann G; God R; Fähr S; Feineis D; Fornadi K; Fornadi F
Anal Biochem; 1999 May; 270(1):167-75. PubMed ID: 10328779
[TBL] [Abstract][Full Text] [Related]
6. TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain.
Bringmann G; God R; Feineis D; Janetzky B; Reichmann H
J Neural Transm Suppl; 1995; 46():245-54. PubMed ID: 8821061
[TBL] [Abstract][Full Text] [Related]
7. Endogenous alkaloids in man. XXVI. Determination of the dopaminergic neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) in biological samples using gas chromatography with selected ion monitoring.
Bringmann G; Friedrich H; Birner G; Koob M; Sontag KH; Heim C; Kolasiewicz W; Fähr S; Stäblein M; God R; Feineis D
J Chromatogr B Biomed Appl; 1996 Dec; 687(2):337-48. PubMed ID: 9017456
[TBL] [Abstract][Full Text] [Related]
8. 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) and related derivatives: chemistry and biochemical effects on catecholamine biosynthesis.
Bringmann G; Feineis D; God R; Peters K; Peters EM; Scholz J; Riederer F; Moser A
Bioorg Med Chem; 2002 Jul; 10(7):2207-14. PubMed ID: 11983518
[TBL] [Abstract][Full Text] [Related]
9. 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH.
Akundi RS; Macho A; Muñoz E; Lieb K; Bringmann G; Clement HW; Hüll M; Fiebich BL
J Neurochem; 2004 Oct; 91(2):263-73. PubMed ID: 15447660
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells.
Storch A; Hwang YI; Bringmann G; Feineis D; Ott S; Brückner R; Schwarz J
J Neural Transm (Vienna); 2006 Dec; 113(12):1895-901. PubMed ID: 16868795
[TBL] [Abstract][Full Text] [Related]
11. Endogenous alkaloids in man. XXXVIII. "Chiral" and "achiral" determination of the neurotoxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) from blood and urine samples by high-performance liquid chromatography--electrospray ionization tandem mass spectrometry.
Bringmann G; Münchbach M; Feineis D; Messer K; Diem S; Herderich M; Clement HW; Stichel-Gunkel C; Kuhn W
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 767(2):321-32. PubMed ID: 11885861
[TBL] [Abstract][Full Text] [Related]
12. The halogenated tetrahydro-beta-carboline "TaClo": a progressively-acting neurotoxin.
Heim C; Sontag KH
J Neural Transm Suppl; 1997; 50():107-11. PubMed ID: 9120411
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and metabolism of the chloral-derived mammalian alkaloid 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) in PC12 cells.
Bringmann G; Feineis D; Münchbach M; God R; Peters K; Peters EM; Mössner R; Lesch KP
Z Naturforsch C J Biosci; 2006; 61(7-8):601-10. PubMed ID: 16989324
[TBL] [Abstract][Full Text] [Related]
14. Effect of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) on human serotonergic cells.
Bringmann G; Brückner R; Mössner R; Feineis D; Heils A; Lesch KP
Neurochem Res; 2000 Jun; 25(6):837-43. PubMed ID: 10944002
[TBL] [Abstract][Full Text] [Related]
15. Modification of tyrosine hydroxylase activity by chloral derived beta-carbolines in vitro.
Riederer F; Luborzewski A; God R; Bringmann G; Scholz J; Feineis D; Moser A
J Neurochem; 2002 May; 81(4):814-9. PubMed ID: 12065640
[TBL] [Abstract][Full Text] [Related]
16. 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) induces apoptosis in human neuroblastoma cell lines.
Akundi RS; Hüll M; Clement HW; Fiebich BL
Ann N Y Acad Sci; 2003 Dec; 1010():304-6. PubMed ID: 15033739
[TBL] [Abstract][Full Text] [Related]
17. 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex I.
Janetzky B; God R; Bringmann G; Reichmann H
J Neural Transm Suppl; 1995; 46():265-73. PubMed ID: 8821063
[TBL] [Abstract][Full Text] [Related]
18. 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Alters Cell Cycle Progression in Human Neuroblastoma Cell Lines.
Sharma RK; Candelario-Jalil E; Feineis D; Bringmann G; Fiebich BL; Akundi RS
Neurotox Res; 2017 Nov; 32(4):649-660. PubMed ID: 28721631
[TBL] [Abstract][Full Text] [Related]
19. Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats.
Sontag KH; Heim C; Sontag TA; God R; Reichmann H; Wesemann W; Rausch WD; Riederer P; Bringmann G
J Neural Transm Suppl; 1995; 46():283-9. PubMed ID: 8821065
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin?
Riederer P; Foley P; Bringmann G; Feineis D; Brückner R; Gerlach M
Eur J Pharmacol; 2002 May; 442(1-2):1-16. PubMed ID: 12020676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
